Nomura Holdings Inc Teva Pharmaceutical Industries LTD Transaction History

Nomura Holdings Inc

$41.1 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$8.12 - $10.63 $121,799 - $159,450	15,000 New	15,000 $156,000
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $156,880 - $206,341	21,789 New	21,789 $164,000
Q4 2022 Feb 15, 2023	BUY	$7.95 - $9.48 $164,445 - $196,093	20,685 New	20,685 $189,000
Q3 2022 Nov 15, 2022	SELL	$6.86 - $11.95 $1.2 Million - $2.09 Million	-174,640 Reduced 63.51%	100,360 $810,000
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $1.02 Million - $1.44 Million	138,553 Added 101.54%	275,000 $2.19 Million
Q1 2022 May 18, 2022	BUY	$7.33 - $9.39 $445,517 - $570,724	60,780 Added 80.33%	136,447 $1.28 Million
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $8,871 - $11,443	1,123 Added 1.51%	75,667 $606,000
Q3 2021 Nov 15, 2021	SELL	$8.38 - $10.18 $120,822 - $146,775	-14,418 Reduced 16.21%	74,544 $743,000
Q2 2021 Aug 16, 2021	SELL	$9.9 - $11.56 $1.05 Million - $1.23 Million	-106,185 Reduced 54.41%	88,962 $892,000
Q1 2021 May 17, 2021	SELL	$10.34 - $12.81 $292,446 - $362,305	-28,283 Reduced 12.66%	195,147 $2.21 Million
Q4 2020 Feb 16, 2021	SELL	$8.61 - $11.04 $861,628 - $1.1 Million	-100,073 Reduced 30.93%	223,430 $2.15 Million
Q3 2020 Nov 12, 2020	BUY	$8.57 - $12.69 $1.07 Million - $1.59 Million	125,374 Added 63.28%	323,503 $2.92 Million
Q2 2020 Aug 14, 2020	SELL	$8.12 - $13.12 $1.34 Million - $2.16 Million	-164,890 Reduced 45.42%	198,129 $2.43 Million
Q1 2020 May 15, 2020	BUY	$6.69 - $13.45 $2.43 Million - $4.88 Million	363,019 New	363,019 $3.22 Million
Q1 2020 May 14, 2020	SELL	$6.69 - $13.45 $476,127 - $957,236	-71,170 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$6.53 - $10.72 $2.26 Million - $3.72 Million	-346,641 Reduced 82.97%	71,170 $697,000
Q3 2019 Nov 14, 2019	BUY	$6.16 - $9.6 $130,370 - $203,174	21,164 Added 5.34%	417,811 $2.84 Million
Q2 2019 Aug 14, 2019	BUY	$8.12 - $15.72 $2.62 Million - $5.08 Million	323,027 Added 438.78%	396,647 $3.7 Million
Q1 2019 May 14, 2019	SELL	$15.58 - $20.01 $610,549 - $784,151	-39,188 Reduced 34.74%	73,620 $1.16 Million
Q4 2018 Feb 14, 2019	SELL	$14.59 - $23.84 $87,671 - $143,254	-6,009 Reduced 5.06%	112,808 $1.83 Million
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $1.54 Million - $1.88 Million	73,244 Added 160.72%	118,817 $2.55 Million
Q2 2018 Aug 14, 2018	SELL	$16.77 - $24.71 $71,674 - $105,610	-4,274 Reduced 8.57%	45,573 $864,000
Q1 2018 May 14, 2018	SELL	$16.68 - $22.07 $1.27 Million - $1.69 Million	-76,412 Reduced 60.52%	49,847 $852,000
Q1 2018 May 14, 2018	BUY	$16.68 - $22.07 $831,447 - $1.1 Million	49,847 Added 65.23%	126,259 $2.3 Million
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $264,286 - $449,499	23,534 Added 44.51%	76,412 $1.45 Million
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $814,849 - $1.7 Million	52,878	52,878 $930,000

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

Black Rock Inc. New York, NY

43M
Shares

$964 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.2M
Shares

$813 Million
35.87% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

34.5M
Shares

$774 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$647 Million
3.32% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$594 Million
14.79% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.9B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Account